Innosphere Launches 2025 Life Sciences Accelerator with 33 High-Impact Startups

Innosphere is proud to announce the 2025 cohort of its Life Sciences Accelerator, featuring 33 startups advancing solutions in biopharma, digital health, diagnostics, medical devices, and more.

Selected from across the country, these ventures are working on innovations ranging from breakthrough AI-powered health technologies, neurodegenerative therapies, at-home lab testing, and novel biology-technology combination therapies. Their work spans key fields including biomedical sciences, AI/ML, neurotechnology, and advanced materials and nanotechnology—areas that reflect our strategic focus and industry demand.

The program is backed by the U.S. Economic Development Administration (EDA) and builds on foundational support from the Colorado Office of Economic Development and International Trade (OEDIT). Innosphere will support the cohort with hands-on development, strategic mentorship, and investor connections—culminating in a national showcase event in December 2025.

“Our 2025 cohort is solving critical health problems with bold science and scalable tech,” said Kevin Noble, Life Sciences Program Director. “We’re excited to help accelerate their journey from lab to market.”

View the full list of companies and descriptions HERE